High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy

Journal of Clinical Microbiology

Volumn 44, Issue 7, 2006, Pages 2409-2415

  Miller, Craig S ^a,b   Berger, Joseph R ^a   Mootoor, Yunanan ^a   Avdiushko, Sergei A ^a   Zhu, Hua ^a   Kryscio, Richard J ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS DNA;

ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; HERPES; HERPES SIMPLEX VIRUS 1; HERPES VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SALIVA ANALYSIS; VIRUS INFECTION; VIRUS LOAD; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; DNA, VIRAL; FEMALE; HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; HIV INFECTIONS; HUMANS; MALE; MOUTH; POLYMERASE CHAIN REACTION; PREVALENCE; SALIVA; VIRAL LOAD;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 33746336963     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00256-06     Document Type: Article

References (75)

1. Antinori, A., A. Cingolani, P. Lorenzini, M. L. Giancola, I. Uccella, S. Bossolasco, S. Grisetti, F. Moretti, B. Vigo, M. Bongiovanni, B. Del Grosso, M. I. Arcidiacono, G. C. Fibbia, M. Mena, M. G. Finazzi, G. Guaraldi, A. Ammassari, A. d'Arminio Monforte, P. Cinque, and A. De Luca. 2003. Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA). J. Neurovirol. 9(Suppl. 1):47-53.
2. Berry, N. J., D. M. Burns, G. Wannamethee, J. E. Grundy, S. F. Lui, H. G. Prentice, and P. D. Griffiths. 1988. Seroepidemiologic studies on the acquisition of antibodies to cytomegalovirus, herpes simplex virus, and human immunodeficiency virus among general hospital patients and those attending a clinic for sexually transmitted diseases. J. Med. Virol. 24:385-393.
3. Blackbourn, D. J., E. T. Lennette, J. Ambroziak, D. V. Mourich, and J. A. Levy. 1998. Human herpesvirus 8 detection in nasal secretions and saliva. J. Infect. Dis. 177:213-216.
4. Boldogh, I., P. Szaniszlo, W. A. Bresnahan, C. M. Flaitz, M. C. Nichols, and T. Albrecht. 1996. Kaposi's sarcoma herpesvirus-like DNA sequences in the saliva of individuals infected with human immunodeficiency virus. Clin. Infect. Dis. 23:406-407.
5. Bower, M., C. Palmieri, and T. Dhillon. 2006. AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy. Curr. Opin. Infect. Dis. 19:14-19.
6. Brengel-Pesce, K., P. Morand, A. Schmuck, M. J. Bourgeat, M. Buisson, G. Bargues, M. Bouzid, and J. M. Seigneurin. 2002. Routine use of real-time quantitative PCR for laboratory diagnosis of Epstein-Barr virus infections. J. Med. Virol. 66:360-369.
7. Cattani, P., M. Capuano, F. Cerimele, I. L. La Parola, R. Santangelo, C. Masini, D. Cerimele, and G. Fadda. 1999. Human herpesvirus 8 seroprevalence and evaluation of nonsexual transmission routes by detection of DNA in clinical specimens from human immunodeficiency virus-seronegative patients from central and southern Italy, with and without Kaposi's sarcoma. J. Clin. Microbiol. 37:1150-1153.
8. Chang, J., R. Renne, D. Dittmer, and D. Ganem. 2000. Inflammatory cytokines and the reactivation of Kaposi's sarcoma-associated herpesvirus lytic replication. Virology 266:17-25.
9. Clifford, D. B., C. Yiannoutsos, M. Glicksman, D. M. Simpson, E. J. Singer, P. J. Piliero, C. M. Marra, G. S. Francis, J. C. McArthur, K. L. Tyler, A. C. Tselis, and N. E. Hyslop. 1999. HAART improves prognosis in HiV-associated progressive multilocal leukoencephalopathy. Neurology 52:623-625.
10. Collot, S., B. Petit, D. Bordessoule, S. Alain, M. Touati, F. Denis, and S. Ranger-Rogez. 2002. Real-time PCR for quantification of human herpesvirus 6 DNA from lymph nodes and saliva. J. Clin. Microbiol. 40:2445-2451.
11. Corey, L., S. Brodie, M. L. Huang, D. M. Koelle, and A. Wald. 2002. HHV-8 infection: a model for reactivation and transmission. Rev. Med. Virol. 12:47-63.
12. Decman, V., P. R. Kinchington, S. A. Harvey, and R. L. Hendricks. 2005. Gamma interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expression. J. Virol. 79:10339-10347.
13. Dedicoat, M., R. Newton, K. R. Alkharsah, J. Sheldon, I. Szabados, B. Ndlovu, T. Page, D. Casabonne, C. F. Gilks, S. A. Cassol, D. Whitby, and T. F. Schulz. 2004. Mother-to-child transmission of human herpesvirus-8 in South Africa. J. Infect. Dis. 190:1068-1075.
14. de Sanjose, S., V. Marshall, J. Sola, V. Palacio, R. Almirall, J. J. Goedert, F. X. Bosch, and D. Whitby. 2002. Prevalence of Kaposi's sarcoma-associated herpesvirus infection in sex workers and women from the general population in Spain. Int. J. Cancer 98:155-158.
15. Druce, J., M. Catton, D. Chibo, K. Minerds, D. Tyssen, R. Kostecki, B. Maskill, W. Leong-Shaw, M. Gerrard, and C. Birch. 2002. Utility of a multiplex PCR assay for detecting herpesvirus DNA in clinical samples. J. Clin. Microbiol. 40:1728-1732.
16. Dukers, N., N. Renwick, M. Prins, R. B. Geskus, T. F. Schulz, G. J. Weverling, R. A. Coutinho, and J. Goudsmit. 2000. Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexual men. Am. J. Epidemiol. 151:213-224.
17. Duus, K. M., V. Lentchitsky, T. Wagenaar, C. Grose, and J. Webster-Cyriaque. 2004. Wild-type Kaposi's sarcoma-associated herpesvirus isolated from the oropharynx of immune-competent individuals has tropism for cultured oral epithelial cells. J. Virol. 78:4074-4084.
18. Falk, K. I., J. Z. Zou, E. Lucht, A. Linde, and I. Ernberg. 1997. Direct identification by PCR of EBV types and variants in clinical samples. J. Med. Virol. 51:355-363.
19. Fidouh-Houhou, N., X. Duval, F. Dissuel, V. Bourbonneux, P. Flandre, J. L. Ecobichon, M. C. Jordan, J. L. Vilde, F. Brun-Vezinet, and C. Leport. 2001. Salivary cytomegalovirus (CMV) shedding, glycoprotein B genotype distribution, and CMV disease in human immunodeficiency virus-seropositive patients. Clin. Infect. Dis. 33:1406-1411.
20. Fons, M. P., C. M. Flaitz, B. Moore, B. S. Prabhakar, C. M. Nichols, and T. Albrecht. 1994. Multiple herpesviruses in saliva of HIV-infected individuals. J. Am. Dent. Assoc. 125:713-719.
21. Gandhi, M., D. M. Koelle, N. Ameli, P. Bacchetti, J. S. Greenspan, M. Navazesh, K. Anastos, and R. M. Greenblatt. 2004. Prevalence of human herpesvirus-8 salivary shedding in HIV increases with CD4 count. J. Dent. Res. 83:639-643.
22. Garside, P., E. Ingulli, R, R. Merica, J, G. Johnson, R. J. Noelle, and M. K. Jenkins. 1998. Visualization of specific B and T lymphocyte interactions in the lymph node. Science 281:96-99.
23. Gentile, G., A. Mele, G. Ragona, A. Faggioni, C. Zompetta, M. E. Tosti, G. Visani, G. Castelli, A. Pulsoni, B. Monarca, P. Martino, and F. Mandelli. 1999. Human herpes virus-6 seroprevalence and leukaemias: a case-control study. GIMEMA (Gruppo Italiano Malattic Ematologiche dell' Adulto). Br. J. Cancer 80:1103-1106.
24. Gopal, M. R., B. J. Thomson, J. Fox, R. S. Tedder, and R. W. Honess. 1990. Detection by PCR of HHV-6 and EBV DNA in blood and oropharynx of healthy adults and HIV-seropositives. Lancet 335:1598-1599.
25. Greenberg, M. S., M. Glick, L. Nghiem, J. C. Stewart, R. Hodinka, and G. Dubin. 1997. Relationship of cytomegalovirus to salivary gland dysfunction in HIV-infected patients. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 83:334-339.
26. Harrington, W. J., Jr., O. Bagasra, C. E. Sosa, L. E. Bobroski, M. Baum. X. L. Wen, L. Cabral, G. E. Byrne, R. J. Pomerantz, and C. Wood. 1996. Human herpesvirus type 8 DNA sequences in cell-free plasma and mononuclear cells of Kaposi's sarcoma patients. J. Infect. Dis. 174:1101-1105.
27. Hatherley, L. I., K. Hayes, and I. Jack. 1980. Herpes virus in an obstetric hospital. II: Asymptomatic virus excretion in staff members. Med. J. Aust. 2:273-275.
28. Hizel, S., S. Parker, and U. Onde. 1999. Seroprevalence of cytomegalovirus infection among children and females in Ankara. Turkey. 1995. Pediatr. Int. 41:506-509.
29. Hung, C. C., C. F. Hsiao, J. L. Wang, M. V. Chen, S. M. Hsieh, W. H. Sheng, and S. C. Chang. 2005. Herpes zoster in HIV-1-infected patients in the era of highly active antiretroviral therapy: a prospective observational study. Int. J. STD AIDS 16:673-676.
30. Idesawa, M., N. Sugano, K. Ikeda, M. Oshikawa, M. Takane, K. Seki, and K. Ito. 2004. Detection of Epstein-Barr virus in saliva by real-time PCR. Oral Microbiol. Immunol. 19:230-232.
31. Ikuta, K., Y. Satoh, Y. Hoshikawa, and T. Sairenji. 2000. Detection of Epstein-Barr virus in salivas and throat washings in healthy adults and children. Microbes Infect. 2:115-120.
32. Kangro, H. O., H. K. Osman, Y. L. Lau, R. B. Heath, C. Y. Yeung, and M. H. Ng. 1994. Seroprevalence of antibodies to human herpesviruses in England and Hong Kong. J. Med. Virol. 43:91-96.
33. Kaufman, H. E., A. M. Azcuy, E. D. Varnell, G. D. Sloop, H. W. Thompson, and J. M. Hill. 2005. HSV-1 DNA in tears and saliva of normal adults. Investig. Ophthalmol. Vis. Sci. 46:241-247.
34. Kelsoe, G. 1996. The germinal center: a crucible for lymphocyte selection. Semin. Immunol. 8:179-184.
35. Kimura, H., M. Morita, Y. Yabuta, K. Kuzushima, K. Kato, S. Kojima, T. Matsuyama, and T. Morishima. 1999. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J. Clin. Microbiol. 37:132-136.
36. Koelle, D. M., M. L. Huang, B. Chandran, J. Vieira, M. Piepkorn, and L. Corey. 1997. Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates. J. Infect. Dis. 176:94-102.
37. LaDuca, J. R., J. L. Love, L. Z. Abbott, S. Dube, A. E. Freidman-Kien, and B. J. Poiesz. 1998. Detection of human herpesvirus 8 DNA sequences in tissues and bodily fluids. J. Infect. Dis. 178:1610-1615.
38. Lampinen, T. M., S. Kulasingam, J. Min, M. Borok, L. Gwanzura, J. Lamb, K. Mahomed, G. B. Woetk, K. B. Strand, M. L. Bosch, D. C. Edelman, N. T. Constantine, D. Katzenstein, and M. A. Williams. 2000. Detection of Kaposi's sarcoma-associated herpesvirus in oral and genital secretions of Zimbabwean women. J. Infect. Dis. 181:1785-1790.
39. Leidner, R. S., and D. M. Ahoulafia. 2005. Recrudescent Kaposi's sarcoma after initiation of HAART: a manifestation of immune reconstitution syndrome. AIDS Patient Care STDs 19:635-644.
40. Levett, P. N. 2005. Seroprevalence of HSV-1 and HSV-2 in Barbados. Med. Microbiol. Immunol. (Berlin) 194:105-107.
41. Li, H., J. S. Dummer, W. R. Estes, S. Meng, P. F. Wright, and Y. W. Tang. 2003. Measurement of human cytomegalovirus loads by quantitative realtime PCR for monitoring clinical intervention in transplant recipients. J. Clin. Microbiol. 41:187-191.
42. Ling, P. D., R. A. Vilchez, W. A. Keitel, D. G. Poston, R. S. Peng, Z. S. White, F. Visnegarwala, D. E. Lewis, and J. S. Butel. 2003. Epstein-Barr virus DNA loads in adult human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy. Clin. Infect. Dis. 37:1244-1249.
43. Lucht, E., P. Biberfeld, and A. Linde. 1995. Epstein-Barr virus (EBV) DNA in saliva and EBV serology of HIV-1-infected persons with and without hairy leukoplakia. J. Infect. 31:189-194.
44. Lucht, E., M. Brytting, L. Bjerregaard, I. Julander, and A. Linde. 1998. Shedding of cytomegalovirus and herpesviruses 6, 7, and 8 in saliva of human immunodeficiency virus type 1-infectcd patients and healthy controls. Clin. Infect. Dis. 27:137-141.
45. Malkin, J. E. 2004. Epidemiology of genital herpes simplex virus infection in developed countries. Herpes 11(Suppl. 1):2A-23A.
46. Mbulaiteye, S. M., M. Walters, E. A. Engels, P. M. Bakaki, C. M. Ndugwa, A. M. Owor, J. J. Goedert, D. Whitby, and R. J. Biggar. 2006. High levels of Epstein-Barr virus DNA in saliva and peripheral blood from Ugandan mother-child pairs. J. Infect. Dis. 193:422-426.
47. Mercader, M., B. Taddeo, J. R. Panella, B. Chandran, B. J, Nickoloff, and K. E. Foreman. 2000. Induction of HHV-8 lytic cycle replication by inflammatory cytokines produced by HIV-1-infected T cells. Am. J. Pathol. 156:1961-1971.
48. Miller, C. S., S. A. Avdiushko, R. J. Kryscio, R. J. Danaher, and R. J. Jacob. 2005. Effect of prophylactic valacyclovir on the presence of human herpes-virus DNA in saliva of healthy individuals after dental treatment. J. Clin. Microbiol. 43:2173-2180.
49. Miller, C. S., L. L. Cunningham, L. J. E., and S. A. Avdiushko. 2004. The efficacy of valacyclovir in preventing recurrent herpes simplex virus infections associated with dental procedures. J. Am. Dent. Assoc. 135:1311-1318.
50. Miralles, P., J. Berenguer, D. Garcia de Viedma, B. Padilla, J. Cosin, J. C. Lopez-Bernaldo deq Uiros, L. Munoz, S. Moreno, and E. Bouza. 1998. Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy. AIDS 12:2467-2472.
51. Navazesh, M. 1993. Methods for collecting saliva. Ann. N. Y. Acad. Sci. 694:72-77.
52. Niederman, J. C. 1982. Infectious mononucleosis: observations on transmission. Yale J. Biol. Med. 55:259-264.
53. Noyola, D. E., B. H. Valdez-Lopez, A. E. Hernandez-Salinas, M. A. Santos-Diaz, M. A. Noyola-Frias, J. F. Reyes-Macias, and L. G. Martinez-Martinez. 2005. Cytomegalovirus excretion in children attending day-care centers. Arch. Med. Res. 36:590-593.
54. Palella, F. J., Jr., K. M. Delaney, A. C. Moorman, M. O. Loveless, J. Fuhrer, G. A. Satten, D. J. Aschman, S. D. Holmberg, et al. 1998. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 338:853-860.
55. Pass, R. F., C. Hutto, R. Ricks, and G. A. Cloud. 1986. Increased rate of cytomegalovirus infection among parents of children attending day-care centers. N. Engl. J. Med. 314:1414-1418.
56. Pauk, J., M. L. Huang, S. J. Brodle, A. Wald, D. M. Koelle, T. Schacker, C. Celum, S. Selke, and L. Corey. 2000. Mucosal shedding of human herpesvirus 8 in men. N. Engl. J. Med. 343:1369-1377.
57. Pevenstein, S. R., R. K. Williams, D. McChesney, E. K. Mont, J. E. Smialek, and S. E. Straus. 1999. Quantitation of latent varicella-zoster virus and herpes simplex virus genomes in human trigeminal ganglia. J. Virol. 73:10514-10518.
58. Ryncarz, A. J., J. Goddard, A. Wald, M. L. Huang, B. Roizman, and L. Corey. 1999. Development of a high-throughput quantitative assay for detecting herpes simplex virus DNA in clinical samples. J. Clin. Microbiol. 37:1941-1947.
59. Sacktor, N. 2002. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J. Neurovirol. 8(Suppl. 2):115-121.
60. Schillinger, J. A., F. Xu, M. R. Sternberg, G. L. Armstrong, F. K. Lee, A. J. Nahmias, G. M. McQuillan, M. E. Louis, and L. E. Markowitz. 2004. National seroprevalence and trends in herpes simplex virus type 1 in the United States, 1976-1994. Sex. Transm. Dis. 31:753-760.
61. Schwartz, R. A. 2004. Kaposi's sarcoma: an update. J Surg. Oncol. 87:146-151.
62. Sirianni, M. C., L. Vincenzi, S. Topino, E. Scala, A. Angeloni, R. Gonnella, S. Uccini, and A. Faggioni. 1997. Human herpesvirus 8 DNA sequences in CD84+ T cells. J. Infect. Dis. 176:541.
63. Sixbey, J. W., P. Shirley, P. J. Chesney, D. M. Buntin, and L. Resnick. 1989. Detection of a second widespread strain of Epstein-Barr virus. Lancet 2:761-765.
64. Slomka, M. J. 1996. Seroepidemiology and control of genital herpes: the value of type specific antibodies to herpes simplex virus. Commun. Dis. Rep. CDR Rev. 6:R41-R45.
65. Smith, J. S., and N. J. Robinson. 2002. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J. Infect. Dis. 186:(Suppl. 1):S3-S28.
66. Springer, K. L., and A. Weinberg. 2004. Cytomegalovirus infection in the era of HAART: fewer reactivations and more immunity. J. Antimicrob. Chemother. 54:582-586.
67. Tateishi, K., Y. Toh, H. Minagawa, and H. Tashiro. 1994. Detection of herpes simplex virus (HSV) in the saliva from 1,000 oral surgery outpatients hy the polymerase chain reaction (PCR) and virus isolation. J. Oral Pathol. Med. 23:80-84.
68. Triantos, D., E. Horefti, E. Paximadi, Z. Kyriakopoulou, G. Karakassiliotis, K. Papanastasiou, M. Lelekis, G. Panos, C. Donta-Bakoyianni, A. Rapidis, and P. Markoulatos. 2004. Presence of human herpes virus-8 in saliva and non-lesional oral mucosa in HIV-infected and oncologic immunocompromised patients. Oral Microbiol. Immunul. 19:201-204.
69. Vieira, J., M. L. Huang, D. M. Koelle, and L. Corey. 1997. Transmissible Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma. J. Virol. 71:7083-7087.
70. Weiss, H. 2004. Epidemiology of herpes simplex virus type 2 infection in the developing world. Herpes 11(Suppl. 1):24A-35A.
71. Whitby, D., M. R. Howard, M. Tenant-Flowers, N. S. Brink, A. Copas, C. Boshoff, T. Hatzioannou, F. E. Suggett, D. M. Aldam, A. S. Denton, et al. 1995. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet 346:799-802.
72. White, I. E., and T. B. Campbell. 2000. Quantitation of cell-free and cell-associated Kaposi's sarcoma-associated herpesvirus DNA by real-time PCR. J. Clin. Microbiol. 38:1992-1995.
73. Wood, C., and W. Harrington, Jr. 2005. AIDS and associated malignancies. Cell Res. 15:947-952.
74. Xu, F., J. A. Schillinger, M. R. Sternberg, R. E. Johnson, F. K. Lee, A. J. Nahmias, and L. E. Markowitz. 2002. Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988-1994. J. Infect. Dis. 185:1019-1024.
75. Zerr, D. M., M. L. Huang, L. Corey, M. Erickson, H. L. Parker, and L. M. Frenkel. 2000. Sensitive method for detection of human herpesviruses 6 and 7 in saliva collected in field studies. J. Clin. Microbiol. 38:1981-1983.